Q1 2023 Earnings Estimate for Stryker Co. Issued By Oppenheimer (NYSE:SYK)
Q1 2023 Earnings Estimate for Stryker Co. Issued By Oppenheimer (NYSE:SYK)
Stryker Co. (NYSE:SYK – Get Rating) – Oppenheimer issued their Q1 2023 earnings estimates for shares of Stryker in a report released on Wednesday, February 1st. Oppenheimer analyst S. Lichtman expects that the medical technology company will post earnings per share of $2.01 for the quarter. The consensus estimate for Stryker's current full-year earnings is $9.83 per share. Oppenheimer also issued estimates for Stryker's Q2 2023 earnings at $2.46 EPS, Q3 2023 earnings at $2.41 EPS, Q4 2023 earnings at $3.12 EPS and FY2024 earnings at $11.11 EPS.
Stryker Co.(紐約證券交易所代碼:SYK-GET Rating)-奧本海默在2月1日星期三發佈的一份報告中發佈了他們對Stryker股票2023年第一季度收益的預期。奧本海默分析師S·利希特曼預計,這家醫療技術公司本季度的每股收益將達到2.01美元。對Stryker目前全年收益的普遍估計是每股9.83美元。奧本海默還發布了對Stryker 2023年第二季度每股收益2.46美元、2023年第三季度每股收益2.41美元、2023年第四季度每股收益3.12美元和2024財年每股收益11.11美元的預期。
Stryker (NYSE:SYK – Get Rating) last posted its earnings results on Tuesday, January 31st. The medical technology company reported $3.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.84 by $0.16. The business had revenue of $5.20 billion for the quarter, compared to analyst estimates of $4.97 billion. Stryker had a net margin of 12.78% and a return on equity of 22.70%. Stryker's revenue was up 10.7% compared to the same quarter last year. During the same period last year, the business posted $2.71 EPS.
Stryker(紐約證券交易所代碼:SYK-GET Rating)最近一次公佈收益結果是在1月31日星期二。這家醫療技術公司公佈本季度每股收益(EPS)為3.00美元,超出分析師普遍預期的2.84美元,超出0.16美元。該業務本季度營收為52億美元,而分析師預期為49.7億美元。Stryker的淨利潤率為12.78%,股本回報率為22.70%。與去年同期相比,Stryker的收入增長了10.7%。去年同期,該業務公佈的每股收益為2.71美元。
Stryker Price Performance
Stryker價格表現
Shares of Stryker stock opened at $282.48 on Thursday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 2.04. The firm's 50-day simple moving average is $247.78 and its 200-day simple moving average is $226.11. Stryker has a twelve month low of $188.84 and a twelve month high of $282.56. The firm has a market cap of $106.90 billion, a P/E ratio of 45.35, a price-to-earnings-growth ratio of 2.83 and a beta of 0.93.
週四,Stryker的股票開盤報282.48美元。該公司的負債權益比率為0.77,速動比率為1.19,流動比率為2.04。該公司的50日簡單移動均線切入位在247.78美元,200日簡單移動均線切入位在226.11美元。Stryker的12個月低點為188.84美元,12個月高位為282.56美元。該公司市值為1,069億美元,市盈率為45.35倍,市盈率為2.83倍,貝塔係數為0.93。
Institutional Investors Weigh In On Stryker
機構投資者看好Stryker
A number of institutional investors and hedge funds have recently bought and sold shares of the company. AMG National Trust Bank increased its position in Stryker by 18.0% during the 3rd quarter. AMG National Trust Bank now owns 18,650 shares of the medical technology company's stock valued at $3,778,000 after buying an additional 2,851 shares in the last quarter. J.W. Cole Advisors Inc. raised its holdings in Stryker by 5.0% in the 3rd quarter. J.W. Cole Advisors Inc. now owns 2,757 shares of the medical technology company's stock worth $558,000 after purchasing an additional 132 shares during the period. Lincoln National Corp raised its holdings in Stryker by 8.0% in the 2nd quarter. Lincoln National Corp now owns 5,668 shares of the medical technology company's stock worth $1,128,000 after purchasing an additional 421 shares during the period. Asset Dedication LLC acquired a new position in shares of Stryker during the third quarter valued at approximately $184,000. Finally, SG Americas Securities LLC raised its holdings in shares of Stryker by 117.7% during the second quarter. SG Americas Securities LLC now owns 18,095 shares of the medical technology company's stock valued at $3,600,000 after acquiring an additional 9,782 shares during the last quarter. 77.10% of the stock is owned by institutional investors.
一些機構投資者和對衝基金最近買賣了該公司的股票。AMG國民信託銀行第三季度將其在Stryker的頭寸增加了18.0%。AMG國民信託銀行現在擁有這家醫療技術公司18,650股股票,價值377.8萬美元,上個季度又購買了2,851股。J.W.Cole Advisors Inc.在第三季度將其持有的Stryker股份增加了5.0%。J.W.Cole Advisors Inc.在此期間又購買了132股,現在擁有2,757股這家醫療技術公司的股票,價值55.8萬美元。林肯國家公司在第二季度增持了8.0%的Stryker股份。林肯國家公司現在擁有5668股醫療技術公司的股票,價值112.8萬美元,在此期間又購買了421股。資產奉獻有限責任公司在第三季度收購了Stryker股票的新頭寸,價值約為18.4萬美元。最後,SG America Securities LLC在第二季度將其持有的Stryker股票增加了117.7%。SG America Securities LLC現在擁有這家醫療技術公司18,095股股票,價值3,600,000美元,上個季度又購買了9,782股。77.10%的股份由機構投資者持有。
Insiders Place Their Bets
內部人士下注
In other news, Director Srikant M. Datar sold 300 shares of the firm's stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $212.36, for a total value of $63,708.00. Following the transaction, the director now owns 4,861 shares of the company's stock, valued at $1,032,281.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Kevin Lobo sold 67,232 shares of Stryker stock in a transaction that occurred on Friday, December 2nd. The stock was sold at an average price of $239.68, for a total value of $16,114,165.76. Following the completion of the transaction, the chief executive officer now owns 80,770 shares in the company, valued at approximately $19,358,953.60. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Srikant M. Datar sold 300 shares of the business's stock in a transaction on Monday, November 7th. The shares were sold at an average price of $212.36, for a total value of $63,708.00. Following the transaction, the director now owns 4,861 shares of the company's stock, valued at approximately $1,032,281.96. The disclosure for this sale can be found here. Over the last three months, insiders have sold 79,139 shares of company stock valued at $19,150,115. Insiders own 6.70% of the company's stock.
其他新聞方面,董事Srikant M.Datar在一筆日期為11月7日(星期一)的交易中出售了300股該公司股票。這隻股票的平均售價為212.36美元,總價值為63,708.00美元。交易完成後,董事現在持有該公司4861股股票,價值1032,281.96美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過這個環節。在其他新聞方面,首席執行官凱文·洛博在12月2日(星期五)的一筆交易中出售了67,232股Stryker股票。這隻股票的平均售價為239.68美元,總價值為16,114,165.76美元。交易完成後,首席執行官現在擁有該公司80,770股,價值約19,358,953.60美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過美國證券交易委員會網站。此外,在11月7日星期一的一次交易中,董事出售了300股該公司的股票。這些股票的平均價格為212.36美元,總價值為63,708.00美元。交易完成後,董事現在持有該公司4861股股票,價值約1032,281.96美元。關於這次銷售的披露可以找到這裏。在過去的三個月裏,內部人士已經出售了79,139股公司股票,價值19,150,115美元。內部人士持有該公司6.70%的股份。
Stryker Increases Dividend
Stryker增加股息
The company also recently announced a quarterly dividend, which was paid on Tuesday, January 31st. Shareholders of record on Friday, December 30th were given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.06%. This is a boost from Stryker's previous quarterly dividend of $0.70. The ex-dividend date of this dividend was Thursday, December 29th. Stryker's dividend payout ratio (DPR) is presently 48.62%.
該公司最近還宣佈了季度股息,股息於1月31日(星期二)支付。12月30日(星期五)登記在冊的股東獲得了0.75美元的股息。這意味着年化股息為3.00美元,收益率為1.06%。這比Stryker之前0.70美元的季度股息有所提振。本次股息除息日期為12月29日星期四。Stryker的股息支付率(DPR)目前為48.62%。
Stryker Company Profile
Stryker公司簡介
(Get Rating)
(獲取評級)
Stryker Corp. operates as a medical technology company. It operates through the following segments: Orthopaedics & Spine and MedSurg & Neurotechnology. The Orthopaedics & Spine segment provides implants for use in total joint replacements, such as hip, knee, and shoulder, and trauma and extremities surgeries.
Stryker Corp.是一家醫療技術公司。它通過以下部門開展業務:整形外科和脊柱以及醫學外科和神經技術。骨科和脊柱部門提供用於全關節置換的植入物,如髖關節、膝蓋和肩部,以及創傷和四肢手術。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Stryker (SYK)
- Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
- Mullen Automotive Stock Gains Momentum On Positive News
- Harley-Davidson Inc. Stock, Is It Time To Buy?
- The Bottom Is In For Meta Platforms, Volatility Is Not Over
- Analyzing Alaska Air's Recent Earnings
- 免費獲取StockNews.com關於Stryker的研究報告(SYK)
- 凱西·伍茲的方舟創新ETF將在2023年反彈?
- 馬倫汽車公司股票因利好消息而上漲
- 哈雷-戴維森公司的股票,是時候買入了嗎?
- Meta平臺的底部已經到了,波動性還沒有結束
- 阿拉斯加航空公司近期收益分析
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
接受Stryker Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Stryker和相關公司的最新新聞和分析師評級的每日簡要摘要。